Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
04/2001
04/05/2001WO2000072867A3 Substantially oil-free cyclosporin compositions
04/05/2001WO2000072820A3 Injectable anesthetic formulation
04/05/2001WO2000069440A3 Nicotine delivery systems
04/05/2001WO2000066126A3 Liposome compositions for improved drug retention
04/05/2001WO2000066087A8 Emulsion-based processes for making microparticles
04/05/2001WO2000060051A8 Arpe-19 as a platform cell line for encapsulated cell-based delivery
04/05/2001WO2000040228A3 Formulations comprising imiquimod or other immune response modifiers for treating mucosal conditions
04/05/2001WO1996018391B1 Use of mono and bicarboxylic acid amides for the manufacture of a medicament active at the peripheral cannabinoid receptor
04/05/2001US20010000143 Using dimethyl ether and elevated temperature/pressure to dissolve the solid; releasing the pressure to precipitate the fine powder and expand the ether into a gas; drugs; vitamins; carotenoid, especially beta-carotene; foods; cosmetics
04/05/2001US20010000142 Improving bioadhesion by covalently bonding anhydride oligomers to a polymer used for microspheres which attach to mucousal membranes in a drug delivery system or for medical diagnoses
04/05/2001DE19947235A1 Neue Kombination von Loteprednol und beta¶2¶-Adrenorezeptor-Agonisten New combination of loteprednol and beta¶2¶-adrenoceptor agonists
04/05/2001DE19946384A1 Verfahren und Vorrichtung zum Spenden haftklebender Laminatabschnitte von einer beweglichen primären auf eine bewegliche sekundäre Trägerbahn Method and device for dispensing pressure-sensitive adhesive laminate sections from a movable primary onto a movable secondary carrier band
04/05/2001DE19945522A1 Pharmazeutisches, wirkstoffhaltiges Gel A pharmaceutical gel containing active ingredients
04/05/2001CA2657208A1 Method of treating inflammatory conditions with progesterone of progesterone analogs
04/05/2001CA2616210A1 Influenza vaccine compositions
04/05/2001CA2388474A1 Vasopressin antagonist formulation and process
04/05/2001CA2388471A1 Pharmaceutical carrier formulation
04/05/2001CA2388438A1 Stable calcitriol solution for packaging in vials
04/05/2001CA2388055A1 Immunostimulatory nucleic acids
04/05/2001CA2388025A1 Therapy with 2-5a and interferon
04/05/2001CA2386312A1 Hydrolyzed cellulose granulations of salts of drugs
04/05/2001CA2386014A1 Influenza vaccine
04/05/2001CA2385990A1 Compositions having improved stability
04/05/2001CA2385989A1 Compositions of tocol-soluble therapeutics
04/05/2001CA2385971A1 Vasopressin agonist formulation and process
04/05/2001CA2385749A1 Melt granulated composition and modified release dosage form prepared from said composition
04/05/2001CA2385748A1 Method and apparatus for locating the injection point of an implanted medical device
04/05/2001CA2385498A1 Method to enhance healing of sternum after sternotomy
04/05/2001CA2379595A1 Oral controlled release formulations
04/04/2001EP1088890A2 Recombinant BPI proteins, uses of BPI proteins, and methods of preparing same
04/04/2001EP1088555A1 Sustained-release preparation
04/04/2001EP1088554A1 Controlled release drug association containing 5-isosorbide mononitrate and acetylsalicylic acid
04/04/2001EP1088551A1 Medicinal compositions for treating evacuatory insufficiency
04/04/2001EP1088549A1 Modafinil having defined particle size
04/04/2001EP1088535A1 Silk clothes for protecting affected parts
04/04/2001EP1088486A2 Stable powder compositions comprising vitamins and/or carotenoids and their preparation
04/04/2001EP1088315A1 Nucleation and growth of magnetic metal oxide nanoparticles and its use
04/04/2001EP1087986A1 7.alpha.-methyl 19-nortestosterone undecanoate with androgenic activity
04/04/2001EP1087835A1 Process for preparing a crystal suspension
04/04/2001EP1087807A2 Medical infusion device with a source of controlled compliance
04/04/2001EP1087800A1 Medical device having anti-infective and contraceptive properties
04/04/2001EP1087788A1 Mucosal targeting immunisation
04/04/2001EP1087773A1 Vaginal active agent delivery procedures and formulations thereof
04/04/2001EP1087772A1 Pharmaceutical tablets comprising an nsaid and a prostaglandin
04/04/2001EP1087766A1 Method of treatment
04/04/2001EP1087762A1 Composition comprising a carnitine and glutathione, useful to increase the absorption of glutathione and synergize its effects
04/04/2001EP1087759A1 Method for manufacturing a laminate consisting of individual layers
04/04/2001EP1087758A1 Method of manufacturing transdermal patches
04/04/2001EP1087757A1 Method for making tablets with active principle sustained-release
04/04/2001EP1087756A1 Particulate acellular tissue matrix
04/04/2001EP1087754A1 Method of forming liposomes
04/04/2001EP1087753A1 Targeted liposomal drug delivery system
04/04/2001EP1087752A2 Method for producing liposomal formulations of active agents
04/04/2001EP1087751A1 Active ingredient delivery systems and devices based on porous matrices
04/04/2001EP1087750A1 Pharmaceutical formulations for aerosols with two or more active substances
04/04/2001EP1087747A1 Foaming composition for hair care
04/04/2001EP1087735A1 Adhesively applied external nasal strips and dilators containing medications and fragrances
04/04/2001EP1018340A9 Inclusion aminoacid salts compounds of benzimidazole derivatives with cyclodextrins, their preparation and pharmaceutical formulations containing them
04/04/2001EP0806900B1 Medicated animal foodstuffs
04/04/2001EP0737052B1 Transdermal drug delivery system
04/04/2001CN1290283A Cross-linked particles
04/04/2001CN1290190A Device for coating to be administered orally
04/04/2001CN1290180A Sterile complex of therapeutic peptide bond to polysaccharide
04/04/2001CN1290177A Crystallographically stable amorphous sephalosporin compositions and process for producing the same
04/04/2001CN1290172A Topical composition containing human epidermal growth factor
04/04/2001CN1290167A Dried or frozen pharmaceutical prepartion containing class III antiarrhythmic compound
04/04/2001CN1290163A Pharmaceuticals comprising N,N'-BIS(2-Hydroxybenzy) ethylenediamine-N, N'-diacetic acid for iron chelating therapy
04/04/2001CN1290162A Taurine derivatives usable in treatment of ophthamic disorders
04/04/2001CN1289714A Electronic dispensing system for Chinese medicines
04/04/2001CN1289602A Chinese medicine for treating cancer by both internal and external applications
04/04/2001CN1289599A Plaster for treating infantile nervous fever
04/04/2001CN1063968C Candy without sugar and for reducing toxic effect of cigarette
04/04/2001CN1063956C Liniment tongibing for cold-type arthralgia
04/04/2001CN1063948C Isatis root preparation and compounding process and use thereof
04/04/2001CN1063947C Chinese medicine Fukang liquid preparing method thereof
04/04/2001CN1063945C External compress paste for discapathy
04/04/2001CN1063944C Method for preparing compound tobramycin suspension for eye
04/04/2001CN1063941C Stable compositons for parenteral administration and method of making same
04/03/2001US6211425 Patch
04/03/2001US6211349 Protonated/acidified nucleic acids and methods of use
04/03/2001US6211296 Hydrogels containing substances
04/03/2001US6211273 Method for preparing malonate methylidene nanoparticles, nanoparticles optionally containing one or several biologically active molecules
04/03/2001US6211250 Percutaneous delivery system
04/03/2001US6211248 Biocompatible solvent for perfluorocarbons and hydrocarbons
04/03/2001US6211243 Methods for treating cold sores with anti-infective compositions
04/03/2001US6211238 Drugs, fungicides and preservatives
04/03/2001US6211207 Pharmaceutical composition
04/03/2001US6211206 Pharmaceutical composition
04/03/2001US6211205 Pharmaceutical composition
04/03/2001US6211194 Solution containing nicotine
04/03/2001US6211171 Administering tricyclic amitriptyline and desipramine to treat neuropathic pain
04/03/2001US6211169 Stable calcitriol solution for packaging into vials
04/03/2001US6211162 Pulmonary delivery of protonated/acidified nucleic acids
04/03/2001US6211152 Formulations for peptide release
04/03/2001US6211144 Stable concentrated insulin preparations for pulmonary delivery
04/03/2001US6210803 Method for the production of a granulate for hemodialysis
04/03/2001US6210742 Emulsions are suited for preparation of food products, personal care products, pharmaceutical products and industrial products
04/03/2001US6210717 System for transporting genes into eukaryotic cells; used for transforming targeted host cell
04/03/2001US6210716 Time-release agent containing antidepressant dosage form; stability
04/03/2001US6210715 Calcium phosphate microcarriers and microspheres